Actemra OPTION Trial Shows Benefit In RA Patients In Combination With Methotrexate
Phase III trial, published in The Lancet, supports the use of Roche’s interleukin-6 inhibitor for rheumatoid arthritis.
Phase III trial, published in The Lancet, supports the use of Roche’s interleukin-6 inhibitor for rheumatoid arthritis.